2023
Age-dependent impairment in antibody responses elicited by a homologous CoronaVac booster dose
Filardi B, Monteiro V, Schwartzmann P, do Prado Martins V, Zucca L, Baiocchi G, Malik A, Silva J, Hahn A, Chen N, Pham K, Pérez-Then E, Miric M, Brache V, Cochon L, Larocca R, Della Rosa Mendez R, Silveira D, Pinto A, Croda J, Yildirim I, Omer S, Ko A, Vermund S, Grubaugh N, Iwasaki A, Lucas C, Initiative Y, Vogels C, Breban M, Koch T, Chaguza C, Tikhonova I, Castaldi C, Mane S, De Kumar B, Ferguson D, Kerantzas N, Peaper D, Landry M, Schulz W. Age-dependent impairment in antibody responses elicited by a homologous CoronaVac booster dose. Science Translational Medicine 2023, 15: eade6023. PMID: 36791210, DOI: 10.1126/scitranslmed.ade6023.Peer-Reviewed Original ResearchConceptsBooster doseAntibody responseNeutralization titersVirus-specific IgG titersOlder adultsAntiviral humoral immunityPlasma antibody responsesHigh-risk populationSARS-CoV-2 spikeYears of ageAge-dependent impairmentHeterologous regimensBooster dosesBooster vaccineCoronaVac vaccineIgG titersProtective immunityHumoral immunityHumoral responseCoronaVacOmicron waveBooster strategyAge groupsEarly controlVaccine
2009
Anamnestic immune response to dengue and decreased severity of yellow fever
Izurieta RO, Macaluso M, Watts DM, Tesh RB, Guerra B, Cruz LM, Galwankar S, Vermund SH. Anamnestic immune response to dengue and decreased severity of yellow fever. Journal Of Global Infectious Diseases 2009, 1: 111-116. PMID: 20300401, PMCID: PMC2840959, DOI: 10.4103/0974-777x.56257.Peer-Reviewed Original ResearchYellow fever infectionAnamnestic immune responseFever infectionDengue antibodiesImmune responseProtective immunityYellow feverDengue type 2 virusYellow fever casesHumoral immune responseCross-sectional studyDengue-2 infectionsPresence of antibodiesIgG-specific antibodiesCross-reactive antibodiesType 2 virusSeroepidemiological methodsLog-linear regression analysisDengue immunityDengue infectionSevere diseaseStudy populationFever casesSeroepidemiological surveyFever
2007
Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia
Sahasrabuddhe VV, Mwanahamuntu MH, Vermund SH, Huh WK, Lyon MD, Stringer JS, Parham GP. Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia. British Journal Of Cancer 2007, 96: 1480-1483. PMID: 17437020, PMCID: PMC2360194, DOI: 10.1038/sj.bjc.6603737.Peer-Reviewed Original ResearchConceptsSquamous cell carcinomaHuman papillomavirusHPV 16High-grade squamous intraepithelial lesionsDistribution of HPVHigh-risk HPV typesCervical cytological abnormalitiesTertiary care centerSquamous intraepithelial lesionsNon-pregnant womenHigh-grade lesionsHigh-risk typesSensitivity of cytologyLiquid-based cytologyHPV-52HPV typesIntraepithelial lesionsProtective immunityCell carcinomaCare centerCytological abnormalitiesHPV assessmentCell countCytologyWomen